Verrica Pharmaceuticals Grants New Equity Awards to Executives Under 2018 Plan
I'm PortAI, I can summarize articles.
Verrica Pharmaceuticals Inc. has granted new equity awards to its executives under the 2018 Equity Incentive Plan. On December 23, 2025, the Compensation Committee approved options for President and CEO Jayson Rieger to purchase 512,269 shares at an exercise price of $8.21 per share. Additionally, Interim CFO John Kirby received 10,000 fully vested restricted stock units. This announcement was published via EDGAR on December 30, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments